2010/12/12

Aurobin

Release form, composition and packing

Ointment for external application of 1 g prednisolone kapronat 2 mg of lidocaine hydrochloride 20 mg D-Panthenol 20 mg 1 mg of triclosan.

Clinico-pharmacological group: drug with anti-inflammatory, antibacterial and mestnoanesteziruyuschim action for topical use in proctology.

Pharmacological action

Combined preparation for local use. Effect of the drug due to the properties of the components in its composition: prednisolone kapronat - non-halogenated corticosteroids, lidocaine hydrochloride - a local anesthetic, D-panthenol - agent, stimulates the regeneration of the epithelium, Triclosan - antibacterial agent with a broad spectrum of action.

The drug has anti-inflammatory, antiallergic, antiexudative, local analgesic, antiseptic and stimulating the regeneration effect.

Pharmacokinetics

Data on the pharmacokinetics of the drug Aurobin not given.

Statement

Processes accompanied by inflammation of the anorectal region:
itching of the anus;
eczema of the perianal area;
Psoriasis perianal region;
perianal dermatitis;
hemorrhoids;
fistula and anal fissures;
anopapillit.

Dosing regimen

The ointment is applied a thin layer on the skin surface 2-4 times per day. When the internal hemorrhoidal nodes small amount of ointment 2-4 times a day injected into the rectum. With a decrease in symptoms ointment is used less frequently (1-2 times / day).

Side effect

Dermatological reactions: seldom - telangiectasia, erythema, and hypertrichosis, the surface skin atrophy (long-term use of the drug).

Other: prolonged use of the drug and / or its application to the vast surface of the skin are possible systemic side effects typical of glucocorticoids. The introduction of excessive amounts of ointment into the rectum may moderate bradycardia.

Contraindications
specific lesion anorectal region (including viral, bacterial and fungal infections);
tumors and precancerous diseases of the skin;
hypersensitivity to the drug.

Pregnancy and lactation

With special caution should be used Aurobin I trimester of pregnancy.

Data about the safety of Aurobina during lactation (breastfeeding) are absent.

Cautions

In the case of applying ointment to a large surface for a long time to consider the possibility of resorption of the systemic circulation of active drug substances.

Overdose

Data on drug overdose Aurobin absent.

Drug Interactions

While using Aurobina and lidocaine for systemic use effects of the latter increases.

Conditions and terms of

The drug should be stored at temperatures not above 15 ° C. Shelf life - 2 years.

No comments:

Post a Comment